• Gastroenteronlogy Conference, all presentations

    Original Date: October 21-22, 2017

    This discounted package includes all of the individual presentations from the conference.

    12.0 CEUs (including 2.5 pharmacy, and 9.5 general) approved by OBNM

  • Mechanisms of IBD: Immunity, Microbiota and the Metabolome

    Presenter: Steven Sandberg-Lewis, ND
    Original Date: October 21, 2017

    Inflammatory bowel disease used to be called “idiopathic”, but many factors are now known to be involved in causation. This presentation will discuss several: diet and nutrient deficiencies, altered fatty acid metabolism; tobacco smoking, medications (aspirin, NSAIDS, antibiotics, hormone replacement) altered gut microbiota, intestinal mucus and bile metabolism; stress and air pollution.

    1.5 CEUs (including 0.25 pharmacy & 1.25 general)approved by OBNM
  • A Systemic Approach to Treating Crohn’s Disease and Ulcerative Colitis

    Presenter: Ilana Gurevich, ND
    Original Date: October 21, 2017

    This is a presentation utilizing the clinical case model to present the latest and most important research on utilizing both naturopathic supplements and medications for treatment of UC and Crohns. Five-six cases are presented to illustrate the different thought patterns and clinical judgments needed when working with these very complex patients. Dr. Gurevich discusses different drug classes that are utilized with this population.

    1.5 CEUs (including 0.75 pharmacy & 0.75 general)approved by OBNM
  • Blueprint for Designing an IBD Diet

    Presenter: Mark Davis, ND
    Original Date: October 21, 2017

    Response to diet in IBD is highly idiosyncratic, and needs to be personalized, but where to start? Dr. Davis presents four blueprints to present to IBD patients, discusses the evidence for each, and talks about why patients and doctors might select one as a blueprint over another.

    1.5 general CEUs approved by OBNM
  • Helminthic Therapy Update

    Presenter: Mark Davis, ND
    Original Date: October 21, 2017

    Helminthic therapy is the introduction of live helminths into the human host to increase immune system robustness, contribute to wellness, and prevent and treat disease. Dr. Davis covers the four commonly used helminths, their mechanisms of action, current literature, and his own clinical and personal experience with helminths.

    1.5 general CEUsapproved by OBNM

  • The Therapeutic Continuum: Comparing the Therapies for IBD

    Presenter: Clyde Jensen, PhD
    Original Date: October 22, 2017

    Therapies can be systematically compared on the basis of benefit, safety, economy and evidence. This presentation shows how to do that using ordinal scaling instruments that help place diverse therapies on a common therapeutic continuum. The presentation then demonstrates the use of the therapeutic continuum in a hypothetical case study of irritable bowel disease in which the pharmacology of several contemporary drugs is presented. The presenter engages the viewer in using an ordinal scaling instrument to place these drugs and other more holistic therapies on a therapeutic continuum for the treatment of the presented case of irritable bowel disease.

    1.5 CEUs (including 0.75 pharmacy & 0.75 general)approved by OBNM

  • Treat the Whole Person: Key Relationships among the Gastrointestinal, Renal and Cardiovascular Systems

    Presenter: Steven Sandberg-Lewis, ND
    Original Date: October 22, 2017

    NDs know that all body systems are integrated and vital force guides the whole. This presentation discusses the relationships among systemic inflammation, dyslipidemia, prothrombotic and profibrogenic states and the common issues of non-alcoholic fatty liver, arterial and renal disease. In addition, this presentation will explore the effects of bariatric surgery on renal function, the effects of hemodialysis on GI function, and the risk of GI bleeding from common medications. Other interactions include acute kidney injury, magnesium deficiency, increased risk of arrhythmias and myocardial infarction from the use of proton pump inhibitors. This presentation also explores the relationships among GI microbiota, probiotics, prebiotics, obesity and kidney disease.

    1.5 CEUs (including 0.25 pharmacy & 1.25 general)approved by OBNM

  • The IBS Naturally Group – Updates from the Field: Research on Naturopathic Approaches to IBS

    Presenter: Joshua Goldenberg, ND
    Original Date: October 22, 2017

    In 2016 the IBS Naturally group was established at the Bastyr University Research Institute. This collection of research investigators and students are dedicated to establishing a solid evidence base for naturopathic approaches to IBS. This group is currently involved in 4 studies on the topic investigating naturopathic dietary approaches to IBS via a Delphi study, an international prospective cohort study of academic naturopathic teaching clinics, biofeedback for IBS via a Cochrane systematic review, and probiotics for IBS via an individual patient data meta-analysis. This presentation provides an update on the current progress and findings of this group.

    1.5 general CEUsapproved by OBNM

  • Naturopathic Approaches to Colon Cancer

    Presenter: Eliot Edwards, ND
    Original Date: October 22, 2017

    Colon cancer is the 3rd most common type of cancer in both men and women in the US. Naturopathic Physicians in a general medicine practice will inevitably see patients who have been diagnosed with colon cancer, or have a strong family history and thus risk factors for developing cancer. What is the role of the ND for these patients?

    Dr. Edwards reviews colon cancer including risk factors, symptoms, assessment and diagnosis, as well as conventional oncology treatment based on NCCN guidelines. Dr. Edwards discusses the strengths and limitations of naturopathic support during conventional cancer care. He explains how naturopathic medicine can help to minimize or manage side effects related to chemotherapies and radiation. He also covers contraindications of naturopathic therapies during conventional treatment. Lastly, he presents naturopathic, nutritional and lifestyle strategies to help prevent colon cancer as well as support patients being treated for colon cancer. Diet, exercise, and nutritional supplementation can highly influence the underlying factors which promote the development of GI cancer. This presentation provides an overview of these factors as they relate to naturopathic primary care.

    1.5 CEUs (including 0.5 pharmacy & 1.0 general)approved by OBNM